Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Guided Therapeutics Inc
GTHP | US
0.23
USD0.02
11.76%
GTHP | US
Loading StockChartView...
About Guided Therapeutics Inc
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/06/2026
Close
0.23
Open
0.23
High
0.23
Low
0.23
View Less
GTHP | US
Risk
160.1
Sharpe
0
Luna's Score
40/100
Recommendation
Sell
Luna says (GTHP | US)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
149.0%1 month
160.1%3 months
176.3%6 months
204.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-5.60
Ent. to rev.
404.04
PEG
-
Other Fundamentals
EBITDA
-2.11M
MarketCap
15.93M
MarketCap(USD)
15.93M
Div. yield
-
Op. margin
-5.58K
Erngs. growth
-
Rev. growth
-72.70
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.05
Range1M
0.06
Range3M
0.22
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.30
Price X volume
1.14K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.60 | 46.09 | Cheaper |
| Ent. to Revenue | 404.04 | 14.34 | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | - | 6.21 | - |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 176.30 | 64.12 | Riskier |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 15.93M | 9.70B | Emerging |
